G9830 Her-2 pos
Also known as: HER2 positive, HER-2 positive breast cancer
Healthcare quality measure documenting Human Epidermal Growth Factor Receptor 2 positive breast cancer status.
In Plain Language
breast cancer protein marker positive; HER2 positive cancer
Clinical Context
Quality measure used in breast cancer oncology to identify patients with HER2-positive tumors, which have prognostic and therapeutic implications, particularly for trastuzumab (Herceptin) eligibility.
RVU Information
CPT G9830 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9830?
CPT G9830 (Her-2 pos) is a G Codes code. Healthcare quality measure documenting Human Epidermal Growth Factor Receptor 2 positive breast cancer status.
Who uses CPT code G9830?
CPT G9830 is used by Oncology, Breast Surgery, Pathology. Quality measure used in breast cancer oncology to identify patients with HER2-positive tumors, which have prognostic and therapeutic implications, particularly for trastuzumab (Herceptin) eligibility.
When is CPT G9830 used?
Quality measure used in breast cancer oncology to identify patients with HER2-positive tumors, which have prognostic and therapeutic implications, particularly for trastuzumab (Herceptin) eligibility.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.